These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7100259)

  • 21. Cardiovascular properties of LF 2.0254, a new potent vasoselective calcium channel blocker with a slow onset of action.
    Pruneau D; Roy F; Brown NL
    Fundam Clin Pharmacol; 1990; 4(2):223-43. PubMed ID: 2112508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive inotropic and negative chronotropic effects of (-)-cis-diltiazem in rat isolated atria.
    Nasa Y; Ichihara K; Yoshida R; Abiko Y
    Br J Pharmacol; 1992 Mar; 105(3):696-702. PubMed ID: 1378343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro analysis of Ca-antagonistic effects of prenylamine as mechanisms for its cardiac actions.
    Hashimoto K; Nakagawa Y; Nabata H; Imai S
    Arch Int Pharmacodyn Ther; 1978 Feb; 231(2):212-21. PubMed ID: 646520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative determination of the cardioselectivity of taxine and verapamil in the isolated aorta, atrium and jejunum preparations of rabbits.
    Tekol Y; Göğüsten B
    Arzneimittelforschung; 1999 Aug; 49(8):673-8. PubMed ID: 10483513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of praeruptorin C and E isolated from 'Qian-Hu' on swine coronary artery and guinea-pig atria.
    Rao MR; Shen XH; Zou X
    Eur J Pharmacol; 1988 Oct; 155(3):293-6. PubMed ID: 3234487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium agonism, a new mechanism for positive inotropy. Hemodynamic effects and mode of action of BAY K 8644.
    Schramm M; Towart R; Kazda S; Thomas G; Franckowiak G
    Adv Myocardiol; 1985; 6():59-70. PubMed ID: 2581301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selectivity scale of calcium antagonists in the human cardiovascular system based on in vitro studies.
    Godfraind T; Salomone S; Dessy C; Verhelst B; Dion R; Schoevaerts JC
    J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S34-41. PubMed ID: 1282611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies.
    Polster P; Christophe B; Van Damme M; Houlliche A; Chatelain P
    J Pharmacol Exp Ther; 1990 Nov; 255(2):593-9. PubMed ID: 1700816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal differences in actions of calcium channel blockers on K+ accumulation, cardiac function, and high-energy phosphate levels in ischemic guinea pig hearts.
    Sato R; Yamazaki J; Nagao T
    J Pharmacol Exp Ther; 1999 May; 289(2):831-9. PubMed ID: 10215660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AK-2-38, a nifedipine analogue with potent smooth muscle calcium antagonist action and partial agonist effects on isolated guinea pig left atrium.
    Matowe WC; Akula M; Knaus EE; Wolowyk MW
    Proc West Pharmacol Soc; 1989; 32():305-7. PubMed ID: 2780609
    [No Abstract]   [Full Text] [Related]  

  • 31. A comparison of several calcium antagonists on uterine, vascular and cardiac muscles from the rat.
    Granger SE; Hollingsworth M; Weston AH
    Br J Pharmacol; 1985 May; 85(1):255-62. PubMed ID: 4027468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of calcium-antagonistic coronary vasodilators on myocardial contractility and membrane potentials.
    Nabata H
    Jpn J Pharmacol; 1977 Apr; 27(2):239-49. PubMed ID: 886659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium antagonistic properties of nicardipine, a dihydropyridine derivative assessed in isolated cerebral arteries and cardiac muscle.
    Nakayama K; Kurihara J; Miyajima Y; Ishii K; Kato H
    Arzneimittelforschung; 1985; 35(4):687-93. PubMed ID: 4015735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dihydropyridines modulate neurotensin inotropic action paradoxically.
    Golba KS; Deja M; Imiołek P; Kotyla PJ; Biernat J; Woś S; Herman ZS
    J Physiol Pharmacol; 1995 Dec; 46(4):419-27. PubMed ID: 8770786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasorelaxant and negative inotropic effects of gallopamil and LU49700, a metabolite of gallopamil, on isolated rat aorta and guinea-pig ventricular myocardium.
    Noguchi K; Takahashi K; Kaneko K; Higuchi S
    Arzneimittelforschung; 1998 Jan; 48(1):22-5. PubMed ID: 9522026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of calmodulin antagonists on tension and cellular calcium content in depolarized vascular and intestinal smooth muscles.
    Karaki H; Murakami K; Nakagawa H; Ozaki H; Urakawa N
    Br J Pharmacol; 1982 Dec; 77(4):661-6. PubMed ID: 7150873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological activity of the new calcium antagonist, lacidipine, on isolated preparations.
    Raddino R; Metra M; Nodari S; Pelá G; Fappani A; Dei Cas L
    Gen Pharmacol; 1996 Oct; 27(7):1255-9. PubMed ID: 8981077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential actions of calcium antagonists on calcium binding to cardiac sarcolemma.
    Pang DC; Sperelakis N
    Eur J Pharmacol; 1982 Jul; 81(3):403-9. PubMed ID: 6981516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium antagonistic drugs. Mechanism of action.
    Church J; Zsotér TT
    Can J Physiol Pharmacol; 1980 Mar; 58(3):254-64. PubMed ID: 7378928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.